eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators
- PMID: 38941059
- PMCID: PMC11436619
- DOI: 10.1007/s11606-024-08899-0
eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators
Abstract
Background: Electronic consultations (eConsults) enable asynchronous consultation between primary care providers (PCPs) and specialists. eConsults have been used successfully to manage a variety of conditions and have the potential to help PCPs manage polypharmacy and promote deprescribing.
Objective: To elicit clinician perspectives on barriers/facilitators of using eConsults for deprescribing among older adults within a university health network.
Design: Semi-structured interviews.
Participants: PCPs, geriatricians, and pharmacists.
Approach: We used the COM-B (Capability, Opportunity, Motivation, and Behavior) model to structure the interview guide and qualitative analysis methods to identify barriers/facilitators of (1) deprescribing and (2) use of eConsults for deprescribing.
Key results: Of 28 participants, 19 were PCPs (13 physicians, 4 residents, 2 nurse practitioners), 7 were geriatricians, and 2 were pharmacists. Barriers and facilitators to deprescribing: PCPs considered deprescribing important but identified myriad barriers (e.g., time constraints, fragmented clinical care, lack of pharmacist integration, and patient/family resistance). Use of eConsults for deprescribing: Both PCPs and geriatricians highlighted the limits of contextual information available through electronic health record (vs. face-to-face) to render specific and actionable eConsults (e.g., knowledge of prior deprescribing attempts). Participants from all groups expressed interest in a targeted process whereby eConsults could be offered for select patients based on key factors (e.g., polypharmacy or certain comorbidities) and accepted or declined by PCPs, with pithy recommendations delivered in a timely manner relative to patient appointments. This was encapsulated by one PCP: "they need to be crisp and to the point to be helpful, with specific suggestions of something that could be discontinued or switched…not, 'hey, did you know your patient is on over 12 medicines?'".
Conclusions: Clinicians identified multifaceted factors influencing the utility of eConsults for deprescribing among older adults in primary care. Deprescribing eConsult interventions should be timely, actionable, and mindful of limitations of electronic chart review.
© 2024. The Author(s), under exclusive licence to Society of General Internal Medicine.
Conflict of interest statement
The authors have declared no conflicts of interest for this article. Dr. Steinman reports receiving royalties from UpToDate and honoraria from the American Geriatrics Society outside of this work.
Similar articles
-
Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives.BMC Geriatr. 2024 May 4;24(1):396. doi: 10.1186/s12877-024-05027-9. BMC Geriatr. 2024. PMID: 38704540 Free PMC article.
-
Factors influencing central nervous system medication deprescribing and behavior change in hospitalized older adults.J Am Geriatr Soc. 2024 Aug;72(8):2359-2371. doi: 10.1111/jgs.19011. Epub 2024 Jun 3. J Am Geriatr Soc. 2024. PMID: 38826146
-
Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.BMJ Open. 2023 Feb 22;13(2):e066234. doi: 10.1136/bmjopen-2022-066234. BMJ Open. 2023. PMID: 36813499 Free PMC article.
-
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475. Health Technol Assess. 2022. PMID: 35894932 Free PMC article. Review.
-
Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis.Res Social Adm Pharm. 2024 Aug;20(8):697-712. doi: 10.1016/j.sapharm.2024.04.014. Epub 2024 Apr 27. Res Social Adm Pharm. 2024. PMID: 38685144 Review.
References
-
- Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-834. 10.1001/jamainternmed.2015.0324. - PubMed
-
- Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;38:3-11. 10.1016/j.ejim.2016.12.021. - PubMed
MeSH terms
Grants and funding
- P30AG044281/AG/NIA NIH HHS/United States
- K12 HS026383/HS/AHRQ HHS/United States
- R61HL157804/HL/NHLBI NIH HHS/United States
- R61 HL157804/HL/NHLBI NIH HHS/United States
- R03AG078804/AG/NIA NIH HHS/United States
- K76AG074924/AG/NIA NIH HHS/United States
- K24AG049057/AG/NIA NIH HHS/United States
- KL2TR001870/TR/NCATS NIH HHS/United States
- P30 AG044281/AG/NIA NIH HHS/United States
- K24 AG054415/AG/NIA NIH HHS/United States
- K24AG067003/AG/NIA NIH HHS/United States
- K12HS026383/Agency for Healthcare Research and Quality
- A141833/PCORI/Patient-Centered Outcomes Research Institute/United States
- UL1 TR991872/TR/NCATS NIH HHS/United States
- K24AG054415/AG/NIA NIH HHS/United States
- P30HS029738/Agency for Healthcare Research and Quality
- 1R24AG064025/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
